Exane Derivatives’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $106K | Buy |
|
|||||
|
2022
Q1 | $281 | Hold |
|
|||||
|
2021
Q4 | $256 | Hold |
|
|||||
|
2021
Q3 | $288 | Hold |
|
|||||
|
2021
Q2 | $292 | Hold |
|
|||||
|
2021
Q1 | $292 | Hold |
|
|||||
|
2020
Q4 | $288 | Sell |
|
|||||
|
2020
Q3 | $4.52K | Hold |
|
|||||
|
2020
Q2 | $5.73K | Hold |
|
|||||
|
2020
Q1 | $4.07K | Hold |
|
|||||
|
2019
Q4 | $5.04K | Sell |
|
|||||
|
2019
Q3 | $9.28K | Sell |
|
|||||
|
2019
Q2 | $431K | Buy |
|
|||||
|
2019
Q1 | $428K | Buy |
|
|||||
|
2018
Q4 | $34.6K | Buy |
|
|||||
|
2018
Q3 | $123 | Sell |
|
|||||
|
2018
Q2 | $198 | Sell |
|
|||||
|
2018
Q1 | $2.02K | Sell |
|
|||||
|
2017
Q4 | $12.8K | Sell |
|
|||||
|
2017
Q3 | $49.3K | Buy |
|